Follow the 엠아이텍 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엠아이텍 has logged 3 insider filings. Market capitalisation: €143.1bn. The latest transaction was disclosed on 2 April 2026 (Sale). Among the most active insiders: 시너지이노베이션. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엠아이텍 是一家在XKRX市场上市的医疗保健和制药公司。它专注于为医疗领域开发创新解决方案。